Skip to Content
Home > Services > Cancer > Clinical Research Trials > Clinical Trial Search > Detail
<< Back to Results
This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearby tissue or lymph nodes. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.
Patient must fit into one of the following three categories:
Christy Moore, RN
Thank you for your feedback!
More Events >>
Get the latest news on the health topics that matter most to you.
© 2018 Spartanburg Regional Healthcare System. All Rights Reserved.